4.6 Review

Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needs

期刊

PARASITES & VECTORS
卷 8, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/s13071-015-0885-3

关键词

STH; Mass drug administration; Preventive chemotherapy; Cost; Cost-effectiveness; Health economics; NTDs; Systematic review; Economic evaluations

资金

  1. London Centre for Neglected Tropical Disease Research (GSK)
  2. Bill & Melinda Gates Foundation [OPP1033751]
  3. Partnership for Child Development
  4. Wellcome Trust [098045]
  5. Bill and Melinda Gates Foundation [OPP1033751] Funding Source: Bill and Melinda Gates Foundation

向作者/读者索取更多资源

Background: In this time of rapidly expanding mass drug administration (MDA) coverage and the new commitments for soil-transmitted helminth (STH) control, it is essential that resources are allocated in an efficient manner to have the greatest impact. However, many questions remain regarding how best to deliver STH treatment programmes; these include which age-groups should be targeted and how often. To perform further analyses to investigate what the most cost-effective control strategies are in different settings, accurate cost data for targeting different age groups at different treatment frequencies (in a range of settings) are essential. Methods: Using the electronic databases PubMed, MEDLINE, and ISI Web of Knowledge, we perform a systematic review of costing studies and cost-effectiveness evaluations for potential STH treatment strategies. We use this review to highlight research gaps and outline the key future research needs. Results: We identified 29 studies reporting costs of STH treatment and 17 studies that investigated its cost-effectiveness. The majority of these pertained to programmes only targeting school-aged children (SAC), with relatively few studies investigating alternative preventive chemotherapy (PCT) treatment strategies. The methods of cost data collection, analysis and reporting were highly variable among the different studies. Only four of the costing studies were found to have high applicability for use in forthcoming economic evaluations. There are also very few studies quantifying the costs of increasing the treatment frequency. Conclusions: The absence of cost data and inconsistencies in the collection and analysis methods constitutes a major research gap for STH control. Detailed and accurate costs of targeting different age groups or increasing treatment frequency will be essential to formulate cost-effective public health policy. Defining the most cost-effective control strategies in different settings is of high significance during this period of expanding MDA coverage and new resource commitments for STH control.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据